ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 36 filers reported holding ASCENDIS PHARMA A/S in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $67,424,000 | -99.9% | 700,000 | +40.0% | 6.19% | -3.1% |
| Q2 2019 | $57,575,000,000 | +79438.9% | 500,000 | -18.7% | 6.39% | -10.8% |
| Q1 2019 | $72,386,000 | +7031.6% | 615,000 | +703.8% | 7.16% | +2362.2% |
| Q2 2016 | $1,015,000 | -81.6% | 76,511 | -75.4% | 0.29% | -86.4% |
| Q2 2015 | $5,502,000 | -6.7% | 311,222 | -8.4% | 2.14% | -17.3% |
| Q1 2015 | $5,896,000 | – | 339,863 | – | 2.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |